A prospective, single-arm phase II clinical study of Toripalimab combined with Fruquintinib in the treatment of pMMR /MSS relapsed and refractory advanced colorectal cancer

ABSTRACT: Interventions: experimental group:Toripalimab combined with Fruquintinib Primary outcome(s): ORR Study Design: Single arm

DISEASE(S): Colorectal Cancer

PROVIDER: 2689685 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR